Literature DB >> 19188629

Neurobiological mechanisms in major depressive disorder.

Marije aan het Rot1, Sanjay J Mathew, Dennis S Charney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19188629      PMCID： PMC2630359          DOI： 10.1503/cmaj.080697

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  79 in total

1.  Toward a comprehensive developmental model for major depression in men.

Authors:  Kenneth S Kendler; Charles O Gardner; Carol A Prescott
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

Review 2.  Stress and the brain: from adaptation to disease.

Authors:  E Ron de Kloet; Marian Joëls; Florian Holsboer
Journal:  Nat Rev Neurosci       Date:  2005-06       Impact factor: 34.870

Review 3.  The mesolimbic dopamine reward circuit in depression.

Authors:  Eric J Nestler; William A Carlezon
Journal:  Biol Psychiatry       Date:  2006-03-29       Impact factor: 13.382

4.  Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.

Authors:  Francis J McMahon; Silvia Buervenich; Dennis Charney; Robert Lipsky; A John Rush; Alexander F Wilson; Alexa J M Sorant; George J Papanicolaou; Gonzalo Laje; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Husseini Manji
Journal:  Am J Hum Genet       Date:  2006-03-20       Impact factor: 11.025

5.  Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children.

Authors:  Joan Kaufman; Bao-Zhu Yang; Heather Douglas-Palumberi; Damion Grasso; Deborah Lipschitz; Shadi Houshyar; John H Krystal; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2006-02-03       Impact factor: 13.382

Review 6.  An update on regional brain volume differences associated with mood disorders.

Authors:  Stephanie Campbell; Glenda MacQueen
Journal:  Curr Opin Psychiatry       Date:  2006-01       Impact factor: 4.741

Review 7.  Pharmacogenomics and antidepressant drugs.

Authors:  Elisabeth B Binder; Florian Holsboer
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

8.  Comorbid painful physical symptoms and depression: prevalence, work loss, and help seeking.

Authors:  Koen Demyttenaere; Anke Bonnewyn; Ronny Bruffaerts; Terry Brugha; Ron De Graaf; Jordi Alonso
Journal:  J Affect Disord       Date:  2006-03-06       Impact factor: 4.839

9.  Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.

Authors:  Deborah E Barnes; George S Alexopoulos; Oscar L Lopez; Jeff D Williamson; Kristine Yaffe
Journal:  Arch Gen Psychiatry       Date:  2006-03

10.  Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces.

Authors:  Roshan Cools; Andy J Calder; Andrew D Lawrence; Luke Clark; Ed Bullmore; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530
View more
  102 in total

1.  Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology.

Authors:  Claudia Ditzen; Ning Tang; Archana M Jastorff; Larysa Teplytska; Alexander Yassouridis; Giuseppina Maccarrone; Manfred Uhr; Thomas Bronisch; Christine A Miller; Florian Holsboer; Christoph W Turck
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

Review 2.  Assessing gene-gene interactions in pharmacogenomics.

Authors:  Hsien-Yuan Lane; Guochuan E Tsai; Eugene Lin
Journal:  Mol Diagn Ther       Date:  2012-02-01       Impact factor: 4.074

Review 3.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

4.  Effects of antidepressants on the performance in the forced swim test of two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions.

Authors:  Giovanna Piras; Osvaldo Giorgi; Maria G Corda
Journal:  Psychopharmacology (Berl)       Date:  2010-06-30       Impact factor: 4.530

5.  Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats.

Authors:  Sergio D Iñiguez; Brandon L Warren; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

6.  Effects of chronic antidepressant treatments in a putative genetic model of vulnerability (Roman low-avoidance rats) and resistance (Roman high-avoidance rats) to stress-induced depression.

Authors:  Giovanna Piras; Maria A Piludu; Osvaldo Giorgi; Maria G Corda
Journal:  Psychopharmacology (Berl)       Date:  2013-07-30       Impact factor: 4.530

7.  The impact of neurochemical mediators on antidepressant effectiveness.

Authors:  Richard J Metzner
Journal:  ACS Chem Neurosci       Date:  2013-09-18       Impact factor: 4.418

8.  Regional alterations of cerebral [18F]FDG metabolism in the chronic unpredictable mild stress- and the repeated corticosterone depression model in rats.

Authors:  Nick Van Laeken; Glenn Pauwelyn; Robrecht Dockx; Benedicte Descamps; Boudewijn Brans; Kathelijne Peremans; Chris Baeken; Ingeborg Goethals; Christian Vanhove; Filip De Vos
Journal:  J Neural Transm (Vienna)       Date:  2018-06-28       Impact factor: 3.575

9.  [Transcranial and invasive brain stimulation for depression].

Authors:  C Plewnia; F Padberg
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

10.  Identification of a potential molecular link between the glucocorticoid and serotonergic signaling systems.

Authors:  Virginia R Falkenberg; Mangalathu S Rajeevan
Journal:  J Mol Neurosci       Date:  2010-01-06       Impact factor: 3.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.